212 related articles for article (PubMed ID: 26089685)
1. Decreased pretreatment lymphocyte/monocyte ratio is associated with poor prognosis in stage Ib1-IIa cervical cancer patients who undergo radical surgery.
Chen L; Zhang F; Sheng XG; Zhang SQ
Onco Targets Ther; 2015; 8():1355-62. PubMed ID: 26089685
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma.
Li GJ; Xu HW; Ji JJ; Yang F; Gao BQ
Onco Targets Ther; 2016; 9():1085-92. PubMed ID: 27042101
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer.
He J; Lv P; Yang X; Chen Y; Liu C; Qiu X
Tumour Biol; 2016 Jul; 37(7):9037-43. PubMed ID: 26762408
[TBL] [Abstract][Full Text] [Related]
6. Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma.
Jiang R; Cai XY; Yang ZH; Yan Y; Zou X; Guo L; Sun R; Luo DH; Chen QY; Huang PY; Xiang YQ; Lu X; Wang L; Xia WX; Mai HQ; Chen MY
Chin J Cancer; 2015 Jun; 34(6):237-46. PubMed ID: 26067059
[TBL] [Abstract][Full Text] [Related]
7. Concurrent Comparison of the Prognostic Values of Tumor Budding, Tumor Stroma Ratio, Tumor Infiltrating Pattern and Lymphocyte-to-Monocyte Ratio in Colorectal Cancer Patients.
Zhang Y; Liu Y; Qiu X; Yan B
Technol Cancer Res Treat; 2021; 20():15330338211045826. PubMed ID: 34658263
[No Abstract] [Full Text] [Related]
8. [Impact of preoperative lymphocyte to monocyte ratio on the prognosis of the elderly patients with stage II(-III( gastric cancer].
Cong X; Li S; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1144-1148. PubMed ID: 27781252
[TBL] [Abstract][Full Text] [Related]
9. [Preoperative Lymphocyte-to-monocyte Ratio Predicts Prognosis in Patients with Stage T1 Non-muscle Invasive Bladder Cancer].
Wang QH; Ji JL; Li H; He PL; Song LX; Zhao Y; Wang HY; Huang T; Sun XX; Cao YW; Dong Z; Shi BB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):622-629. PubMed ID: 31699192
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of the Preoperative Lymphocyte to Monocyte Ratio in Patients with Gallbladder Carcinoma.
Xu W; Wu X; Wang X; Yu S; Xu G; Xiong J; Zhang J; Sang X; Zheng Y; Liu W
Cancer Manag Res; 2020; 12():3271-3283. PubMed ID: 32494191
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of pretreatment lymphocyte/monocyte ratio in retroperitoneal liposarcoma patients after radical resection.
Luo P; Cai W; Yang L; Chen S; Wu Z; Chen Y; Zhang R; Shi Y; Yan W; Wang C
Cancer Manag Res; 2018; 10():4727-4734. PubMed ID: 30425569
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T
Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209
[TBL] [Abstract][Full Text] [Related]
13. Pre-operative lymphocyte-to-monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma.
Liu T; Fang XC; Ding Z; Sun ZG; Sun LM; Wang YL
FEBS Open Bio; 2015; 5():682-7. PubMed ID: 26380812
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma.
Hutterer GC; Sobolev N; Ehrlich GC; Gutschi T; Stojakovic T; Mannweiler S; Pummer K; Zigeuner R; Pichler M; Dalpiaz O
J Clin Pathol; 2015 May; 68(5):351-5. PubMed ID: 25661796
[TBL] [Abstract][Full Text] [Related]
15. The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancer.
Zhou X; Du Y; Xu J; Huang Z; Qiu T; Wang X; Qian J; Zhu W; Liu P
Tumour Biol; 2014 Nov; 35(11):11659-66. PubMed ID: 25139101
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte to monocyte ratio is associated with response to first-line platinum-based chemotherapy and prognosis of early-stage non-small cell lung cancer patients.
Song YJ; Wang LX; Hong YQ; Lu ZH; Tong Q; Fang XZ; Tan J
Tumour Biol; 2016 Apr; 37(4):5285-93. PubMed ID: 26561466
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: A meta-analysis.
Ma JY; Liu Q
Int J Surg; 2018 Feb; 50():67-71. PubMed ID: 29329786
[TBL] [Abstract][Full Text] [Related]
18. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
[TBL] [Abstract][Full Text] [Related]
19. Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival.
Peng J; Li H; Ou Q; Lin J; Wu X; Lu Z; Yuan Y; Wan D; Fang Y; Pan Z
Onco Targets Ther; 2017; 10():3789-3799. PubMed ID: 28794643
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer with special reference to myeloid-derived suppressor cells.
Shimura T; Shibata M; Gonda K; Hayase S; Sakamoto W; Okayama H; Fujita S; Saito M; Momma T; Ohki S; Kono K
Fukushima J Med Sci; 2018 Aug; 64(2):64-72. PubMed ID: 30012939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
